Back the Biotech Company Unlocking Mushroom Health Benefits for All

Functional mushrooms can boost mental, gut, and immune health-but people can't grow them at home. One company is making it easy with a patent-pending kitchen device. Think Nespresso, but for mushrooms. The functional mushroom market is projected to nearly double by 2030.

Transmedics Group Inc
NASDAQ:TMDX
$116.05
Open 116.05 Prev Close 116.05
High 116.05 Low 116.05
Volume 0 Volume (Avg) 1,108
52 Week High 177.37 52 Week Low 55.00
Market Cap 4B PE Ratio 60.01

General

NameTransmedics Group Inc
TickerTMDX
ExchangeNASDAQ
SectorHealthcare
IndustryMedical Devices
CurrencyUSD
CountryUSA
Fiscal Year EndDecember
Full Time Employees728

About Transmedics Group Inc

TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and customized technology to replicate near-physiologic conditions for donor organs outside of the human body. Its OCS includes OCS LUNG for the preservation of standard criteria donor lungs for double-lung transplantation; OCS Heart, a technology for preservation of DBD donor hearts deemed unsuitable due to limitations of cold storage and for ex vivo reanimation, functional monitoring, and beating-heart preservation of donation-after-circulatory-death hearts; and OCS Liver for the preservation of DBD and DCD of donor livers. The company also developed national OCS program, a turnkey solution for outsourced organ retrieval; and provides OCS organ management and logistics services, including aviation and ground transportation, and other coordination activity. The company was founded in 1998 and is headquartered in Andover, Massachusetts.

Highlights

Analyst Target146.38
Market Cap3,956,200,000
PE Ratio60.01
EBITDA100,302,000

Valuation

Trailing PE58.61
Forward PE50.76
Price/Sales (Trailing 12 Mt.)7.62
Price/Book (Most Recent Quarter)12.73

Technicals

Beta2.18
52 Week High177.37
52 Week Low55
50 Day Average-6.55%
200 Day Average27.07%

Earnings

Most Popular

Marjorie Taylor Greene Increases These 2 Stocks In Portfolio, Including This AI Name Up Over 100% YTD

Marjorie Taylor Greene has bought stocks multiple times in 2025 and her recent disclosure adds to one of the stocks that drew the biggest red flags in 2025.

These 3 Dividend-Yielding Stocks Could Outperform As High Fed Rates Spark $4.9 Billion Inflows: Expert

Expert highlights the top high divided yielding stocks and funds that investors could consider to seize the opportunity amid high Fed rates.

Weiss Gold Veteran Makes Shocking New Call - Ad

Weiss expert Sean Brodrick went out on a limb last year and declared a historic event would send the yellow metal to $3,150. People laughed at him at the time, but he was off by just two days. Now, Sean has a shocking new prediction for gold ... and reveals a little-known way to get ahead of this bull market.

Russia insists on achieving Ukraine goals despite Trump's ultimatum

Russia is open to peace with Ukraine, but achieving its goals remains a priority, Kremlin spokesman Dmitry Peskov said Sunday, days after U.S. President to agree to a ceasefire or .

Paula Deen has abruptly closed the Savannah restaurant that launched her to Food Network fame

SAVANNAH, Ga. (AP) — Former Food Network star Paula Deen announced Friday the abrupt closure of the Savannah restaurant that launched her to fame with its menu of fried chicken, banana pudding and other indulgent Southern dishes.

How to Hack a $1.3T Market - Ad

Forget concrete. The new foundation for real estate success is digital, and Pacaso leads the way. Their tech unlocks a $1.3T real estate market. They've already earned $110M+ in gross profits in their operating history and reserved the Nasdaq ticker PCSO.

Back This Medical AI Tech - Ad

You don't often find healthcare tech company valued at $4M. HeartSciences is an exception. With $75M invested, including R&D, clinical trials, and product development, their patented AI software is approaching FDA submission, a potential major inflection point.

Trump to visit Federal Reserve headquarters as feud with its chair continues

WASHINGTON (AP) — President Donald Trump is visiting the Federal Reserve headquarters in Washington Thursday, a week after indicating that Fed chair Jerome Powell's on two Fed buildings could be grounds for firing.

Better Than Bitcoin? (Top Crypto for Less Than $1) - Ad

Over the past 15 years, Bitcoin has outperformed stocks, bonds, and every other asset you could've bought. 2025 is already shaping up to be another banner year, with Bitcoin recently hitting a new all-time high. But there's a better way to profit from this new crypto rally. Most people don't know about it... and yet it's returned over 1,000% in 4 months. This could be the #1 way to invest in crypto right now.

Tim Walz: Trump 'Brings Out the Worst in Me'

Gov. Tim Walz (D-Minn.) offered a candid reflection on his rhetoric toward Donald Trump, acknowledging regret over earlier inflammatory comments made during the 2024 presidential campaign.

Tap Into the $65B 'Shroom Boom' - Ad

People are rapidly discovering how mushrooms can enhance brain function, gut health, immunity, and more. The only thing holding them back? A simple way to grow them. Hypha Labs built a compact countertop device to solve exactly that.

Retirees, here’s how to tweak the 4% rule to protect your nest egg

New retirees might enter a different environment than their predecessors—the economy or market might have changed slightly or dramatically.

FDA Lifts Safety Hold On Sarepta's Muscular Dystrophy Gene Therapy—Wall Street Cheers

Sarepta stock sees upgrades and price hikes as analysts reassess Elevidys prospects following a favorable FDA development.

The Surprising New Date That Could Fuel the AI Boom - Ad

Trump's economic blueprint is about to go live, and the deadline is fast-approaching. A new federal plan could legally unlock $100 trillion in U.S. resources... and one $10 stock could lead the charge. Former hedge fund manager Whitney Tilson explains how to act now, before this hits the headlines.

EU and Japan agree to work together to promote free trade and economic security

TOKYO (AP) — Leaders of the and Japan launched an alliance Wednesday aimed at boosting economic cooperation, defending free trade and countering unfair trade practices as the two sides face growing challenges from the United States and China.

Britain and Australia to sign 50-year nuclear submarine treaty

MELBOURNE, Australia (AP) — Britain and Australia announced they will sign a cooperation treaty to build Australian nuclear-powered submarines and welcomed a review by administration of the United States' role in the trilateral defense deal.

Trading Isn't Your Job. Let the System Handle It. - Ad

HiveMind AI handles trades for you-based on logic, not gut instinct. Built by pro traders. Runs 24/7. No emotions. No second-guessing. Want to deploy capital smarter?

Berkshire Hathaway Faces $3.8 Billion Loss Tied to Kraft Heinz Stake

Berkshire Hathaway has reported a $3.8 billion impairment on its stake in Kraft Heinz, marking a significant setback for the billionaire investor.

Ethereum, XRP, SOL Surge After GENIUS Act: What's Driving The Altcoin Rally?

The altcoin rally may only be getting started and follows the signing of the GENIUS Act, the most significant U.S. crypto legislation to date, ushering in structural clarity for digital assets.

FDA Submission Expected This Summer - Invest Before It Happens - Ad

This company is making heart disease easier to detect with AI. Their tech has officially been designated a "Breakthrough" by the FDA. You now have an opportunity to get in at a potential inflection point.

Anthropic Study Shows AI Chatbots Can Transfer Their Bad Habits Through Hidden Signals In Data

AI systems can pick up hidden biases from data, leading to safety concerns. Study shows this can happen even with small models sharing architecture.

Is Your Capital Following a Real Strategy? - Ad

Trade with $100K-$200K funded capital-no manual trading. Our AI system skips charts, eliminates stress, and lands you funding. Thousands passed prop challenges with us. Apply now, book a call, and have $10K ready.

Back the Biotech Company Unlocking Mushroom Health Benefits for All - Ad

Functional mushrooms can boost mental, gut, and immune health-but people can't grow them at home. One company is making it easy with a patent-pending kitchen device. Think Nespresso, but for mushrooms. The functional mushroom market is projected to nearly double by 2030.

Shiba Inu Could Surge 3,000% and Overtake Dogecoin by 2026, Say Analysts

Memecoin Shiba Inu (CRYPTO: SHIB) is expected to outperform Dogecoin (CRYPTO: DOGE) in the forthcoming bull cycle, as per analysts’ predictions.

Weiss Gold Veteran Makes Shocking New Call - Ad

Weiss expert Sean Brodrick went out on a limb last year and declared a historic event would send the yellow metal to $3,150. People laughed at him at the time, but he was off by just two days. Now, Sean has a shocking new prediction for gold ... and reveals a little-known way to get ahead of this bull market.

How to Hack a $1.3T Market - Ad

Forget concrete. The new foundation for real estate success is digital, and Pacaso leads the way. Their tech unlocks a $1.3T real estate market. They've already earned $110M+ in gross profits in their operating history and reserved the Nasdaq ticker PCSO.

Japanese leader Ishiba vows to remain despite speculation, says he will focus on new US trade deal

TOKYO (AP) — Prime Minister on Wednesday vowed to remain in power to oversee the implementation of a , despite media speculation and growing calls for him to resign after a .

Back This Medical AI Tech - Ad

You don't often find healthcare tech company valued at $4M. HeartSciences is an exception. With $75M invested, including R&D, clinical trials, and product development, their patented AI software is approaching FDA submission, a potential major inflection point.

Most Recent

Information, charts or examples are for illustration and educational purposes only and not for individualized investment management This message contains commercial elements, such as advertising. We only send these offers to those who have opted in to our newsletter. Past performance is not indicative of future results. For these reasons we strongly suggest trading in a DEMO/Simulated account. The information provided by us is for educational and informational purposes only. We make no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended and have not determined if the statements and opinions of the advertiser are accurate, correct or truthful. If you use, act upon or make decisions in reliance on information contained or any external source linked within it, you do so at your own peril and agree to hold us, our officers, directors, shareholders, affiliates and agents without fault.

Copyright smartmoneytrading.net
Privacy Policy | Terms of Service